Last reviewed · How we verify
VVN001 Ophthalmic Solution, Vehicle
VVN001 Ophthalmic Solution, Vehicle is a topical ophthalmic solution used to facilitate the administration of other eye medications.
VVN001 Ophthalmic Solution, Vehicle is a topical ophthalmic solution used to facilitate the administration of other eye medications. Used for Administration of other eye medications.
At a glance
| Generic name | VVN001 Ophthalmic Solution, Vehicle |
|---|---|
| Sponsor | VivaVision Biotech, Inc |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
It serves as a vehicle to help deliver other drugs directly to the eye, potentially improving their efficacy and reducing systemic side effects. The exact mechanism of action is not well-documented, but it is believed to work by providing a stable and consistent delivery system for other medications.
Approved indications
- Administration of other eye medications
Common side effects
Key clinical trials
- Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease (PHASE3)
- Study of VVN001 Ophthalmic Solution in Dry Eye Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VVN001 Ophthalmic Solution, Vehicle CI brief — competitive landscape report
- VVN001 Ophthalmic Solution, Vehicle updates RSS · CI watch RSS
- VivaVision Biotech, Inc portfolio CI